W. Wahli

Discipline

Histoire, Philosophie et Sociologie des sciences (4) Psychologie (3) Education (3) Science politique (1) Musique, musicologie et arts de la scène (1) Sciences de l'information et de la communication (1) Géographie (1) Art et histoire de l'art (1) Anthropologie biologique (1)

Type de document

Articles (89) Recensions (21)

Co-auteur

Date

Source

Mot-clé

Mice (54) Animals (48) Expression (34) Inflammation (32) Metabolism (30) Liver (30) Receptors (30) métabolisme (28) Human beings (28) Metabolism (28) Treatment (27) Genes (26) lipide (23) Transcription (23) Cells (23) Transcription (23) gène (21) Development (21) Control (21) Homeostasis (21) Glucose (20) acide (19) maladie (19) règlement (19) Lipids--Metabolism (19) Regulation (19) maladie (19) puits (18) protéine (18) effet (18)

Documents écrit par W. Wahli (89) | parle de W. Wahli (0)

PPARs as Key Transcription Regulators at the Crossroads of Metabolism and Inflammation.
W. Wahli (18 avr. 2024)
GDF15 activates AMPK and inhibits gluconeogenesis and fibrosis in the liver by attenuating the TGF-β1/SMAD3 pathway.
E. Barroso et al.
The Opioid Receptor Influences Circadian Rhythms in Human Keratinocytes through the β-Arrestin Pathway.
P. Bigliardi et al. (25 janv. 2024)
Elafibranor upregulates the EMT-inducer S100A4 via PPARβ/δ.
M. Zhang et al.
Striking a gut-liver balance for the antidiabetic effects of metformin.
E. Barroso et al.
A positive feedback loop between AMPK and GDF15 promotes metformin antidiabetic effects.
E. Barroso et al.
Knocking on GDF15's door for the treatment of type 2 diabetes mellitus.
E. Barroso et al.
Peroxisomal Proliferator-Activated Receptor β/δ Deficiency Induces Cognitive Alterations.
O. Busquets et al. (11 juil. 2022)
ATGL-dependent white adipose tissue lipolysis controls hepatocyte PPARα activity.
A. Fougerat et al. (7 juin 2022)
PPARs as Key Mediators in the Regulation of Metabolism and Inflammation.
W. Wahli (30 avr. 2022)
The hepatocyte insulin receptor is required to program the liver clock and rhythmic gene expression.
T. Fougeray et al. (12 avr. 2022)
Integrative study of diet-induced mouse models of NAFLD identifies PPARα as a sexually dimorphic drug target.
S. Smati et al.
Nuclear HMGB1 protects from nonalcoholic fatty liver disease through negative regulation of liver X receptor.
J. Personnaz et al. (25 mars 2022)
Adipose-Specific PPARα Knockout Mice Have Increased Lipogenesis by PASK-SREBP1 Signaling and a Polarity Shift to Inflammatory Macrophages in White Adipose Tissue.
T.D. Hinds et al. (2022)
GDF15 mediates the metabolic effects of PPARβ/δ by activating AMPK.
E. Barroso et al. (10 août 2021)
The PPARβ/δ-AMPK Connection in the Treatment of Insulin Resistance.
X. Palomer et al. (9 août 2021)
Roles of Estrogens in the Healthy and Diseased Oviparous Vertebrate Liver.
B. Tramunt et al. (30 juil. 2021)
PPARs and Tumor Microenvironment: The Emerging Roles of the Metabolic Master Regulators in Tumor Stromal-Epithelial Crosstalk and Carcinogenesis.
H.S. Cheng et al. (29 avr. 2021)
The pregnane X receptor drives sexually dimorphic hepatic changes in lipid and xenobiotic metabolism in response to gut microbiota in mice.
S.A. Barretto et al. (20 avr. 2021)
Invalidation of the Transcriptional Modulator of Lipid Metabolism PPARβ/δ in T Cells Prevents Age-Related Alteration of Body Composition and Loss of Endurance Capacity.
A.S. Rousseau et al. (2021)
Oxidative Stress in NAFLD: Role of Nutrients and Food Contaminants.
C. Rives et al. (21 déc. 2020)
Peroxisome Proliferator-Activated Receptors as Molecular Links between Caloric Restriction and Circadian Rhythm.
K. Duszka et al. (12 nov. 2020)
PPARs and Microbiota in Skeletal Muscle Health and Wasting.
R. Manickam et al. (29 oct. 2020)
Mechanistic definition of the cardiovascular mPGES-1/COX-2/ADMA axis.
N.S. Kirkby et al. (1 oct. 2020)
Peroxisome Proliferator-Activated Receptors and Caloric Restriction-Common Pathways Affecting Metabolism, Health, and Longevity.
K. Duszka et al. (16 juil. 2020)

next